[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100643615":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":25,"responsibleParty":44,"collaborators":46,"id":50,"slug":18,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":51,"sex":57,"minAge":18,"maxAge":18,"enrollmentInfo":58,"targetDuration":18,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":70,"overallStatus":28,"whyStopped":18,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"CareAcross","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm 1 - Experimental","EXPERIMENTAL","Participants in this group utilize the personalized digital platform to record adverse events as Patient-Reported Outcomes (PROs). Additionally, they receive short textual personalized educational and supportive material online.\n\nTheir standard clinical treatment and monitoring continue unaffected.",[13],"Behavioral: Digital support",{"label":15,"type":16,"description":17,"interventionNames":18},"Arm 2 - Control","NO_INTERVENTION","Participants in this group utilize the personalized digital platform to record adverse events as Patient-Reported Outcomes (PROs). They only receive an acknowledgement of their submission.\n\nTheir standard clinical treatment and monitoring continue unaffected.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Digital support","Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.",[9],[26],{"facility":27,"status":28,"city":29,"state":18,"zip":30,"country":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Alexandra General Hospital","RECRUITING","Athens","11528","Greece",{"type":33,"coordinates":34},"Point",[35,36],23.72784,37.98376,{"lat":36,"lon":35},[39],{"name":40,"role":41,"phone":42,"phoneExt":18,"email":43},"Professor Evangelos Terpos","CONTACT","+302132162846","eterpos@med.uoa.gr",{"type":45,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[47],{"name":48,"class":49},"Μedical Association for the Study of Cancer Biology and Treatments (Μ.Α.S.CA.B.T.)","UNKNOWN","100643615",false,"NCT07642362","Digital Support for Multiple Myeloma Quality of Life","Digital Support for Enhancing the Quality of Life of Patients With Multiple Myeloma: An Observational, Randomized, Prospective Study (DigiMyQoL)","DigiMyQoL","Inclusion Criteria:\n\n* Adult patients with newly diagnosed or relapsed\u002Frefractory multiple myeloma\n* Patients that are able to use the digital platform\u002Fapplication\n\nExclusion Criteria:\n\n* Patients that are not able to use the digital platform\u002Fapplication","ALL",{"count":59,"type":60},108,"ESTIMATED","INTERVENTIONAL",[63],"NA","The objective of this prospective study is to investigate the quality of life of patients with multiple myeloma and the effectiveness of support provided through a personalized web-based platform.\n\nSpecifically, the study will compare Patient-Reported Outcomes (PROs) and the associated improvement in side effects and quality of life achieved through appropriate personalized educational and supportive content.",[66,67,68,69],"Multiple Myeloma","Patient Reported Outcome (PRO)","Supportive Care in Cancer","Quality of Life",[71,72,73,74,75,76,77],"multiple myeloma","quality of life","qol","patient reported outcome","pro","digital oncology","supportive care","2026-06-07",{"date":80,"type":81},"2026-06-11","ACTUAL",{"date":83,"type":81},"2025-02-27",{"date":85,"type":60},"2028-03",{"name":5,"class":6},1]